Fig. 2From: A prognostic model based on cell-cycle control predicts outcome of breast cancer patientsThe combination of immunoexpressions for Securin and Separase indicate favorable (Securin a and Separase b) vs unfavorable (Securin c and Separase d) outcome of breast cancerBack to article page